PVALB and schizophrenia: Expression of DISC1ΔC under the control of the CaMKII promoter in a transgenic mouse line resulted in several phenotypes related to schizophrenia including enlarged lateral ventricles, reduction in parvalbumin immunoreactivity, reduced cortical dopamine levels and behavioral abnormalities [10].